Clinical trial
Impact of Hemodialysis on Exhaled Volatile Organic Compounds in End Stage Renal Disease
NCT01684228 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Hemodialysis on Exhaled Volatile Organic Compounds in End Stage Renal Disease
- Lead sponsor
- Rambam Health Care Campus
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- September 30, 2012
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease